Comparison of oncological benefits of deep neuromuscular block in obese patients with gastric cancer (DEBLOQS_GC study) A study protocol for a double-blind, randomized controlled trialopen access
- Authors
- Lee, Yoontaek; Ha, Donghwan; An, Liang; Jang, You-Jin; Huh, Hyub; Lee, Chang Min; Kim, Yeon-Hee; Kim, Jong-Han; Park, Seong-Heum; Mok, Young-Jae; Lee, Il Ok; Kwon, Oh Kyoung; Kwak, Kyung Hwa; Min, Jae Seok; Kim, Eun Jin; Choi, Sung Il; Yi, Jae Woo; Jeong, Oh; Jung, Mi Ran; Bae, Hong Bum; Park, Joong-Min; Jung, Yong Hoon; Kim, Jin-Jo; Kim, Dal Ah; Park, Sungsoo
- Issue Date
- Dec-2018
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Keywords
- gastric neoplasm; laparoscopy; lymphadenectomy; neuromuscular block
- Citation
- MEDICINE, v.97, no.49
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- MEDICINE
- Volume
- 97
- Number
- 49
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/2891
- DOI
- 10.1097/MD.0000000000013424
- ISSN
- 0025-7974
1536-5964
- Abstract
- Purpose: Many studies have demonstrated the advantage of maintaining intraoperative deep neuromuscular block (NMB) with sugammadex. This trial is designed to evaluate the impact of muscle relaxation during laparoscopic subtotal gastrectomy on the oncological benefits, particularly in obese patients with gastric cancer. Materials and methods: This is a double-blind, randomized controlled multicenter prospective trial. Patients with clinical stage III gastric cancer with a body mass index of 25 and over, who undergo laparoscopic subtotal gastrectomy will be eligible for trial inclusion. The patients will be randomized into a deep NMB group or a moderate NMB group with a 1: 1 ratio. A total of 196 patients (98 per group) are required. The primary endpoint is the number of harvested lymph nodes, which is a critical index of the quality of surgery in gastric cancer treatment. The secondary endpoints are surgeon's surgical condition score, patient's sedation score, and surgical outcomes including peak inspiratory pressure, operation time, postoperative pain, and morbidity. Discussion: This is the first study that compares deep NMB with moderate NMB during laparoscopic gastrectomy in obese patients with gastric cancer. We hope to show the oncologic benefits of deep NMB compared with moderate NMB during subtotal gastrectomy.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Anesthesiology and Pain Medicine > 1. Journal Articles
- 2. Clinical Science > Department of Foregut Surgery > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.